Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS2 | P35228 | 8/20 | 0.47 |
| ▸ | NOS1 | P29475 | 6/20 | 0.47 |
| ▸ | NOS3 | P29474 | 5/20 | 0.47 |
| ▸ | ARG1 | P05089 | 1/20 | 0.44 |
| ▸ | ARG2 | P78540 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.42 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.41 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.41 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.41 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.39 |
| ▸ | GRM8 | O00222 | 1/20 | 0.39 |
| ▸ | GRM6 | O15303 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29008680 | 1.00 | NOS2 (0.47) | NOS2NOS1NOS3ARG1ARG2 | |
| Cystine SCHEMBL5223305 | 0.90 | NOS2 (0.50) | NOS2NOS1NOS3ARG1ARG2 | |
| Cystine SCHEMBL5223299 | 0.90 | NOS2 (0.50) | NOS2NOS1NOS3ARG1ARG2 | |
| Cystine SCHEMBL10224 | 0.90 | PTGS1 (0.50) | NOS2NOS1NOS3ARG1ARG2 | |
| SCHEMBL4922553 | 0.90 | NOS2 (0.35) | NOS2NOS1NOS3ARG1ARG2 | |
| Cystine SCHEMBL10225 | 0.90 | PTGS1 (0.50) | NOS2NOS1NOS3ARG1ARG2 | |
| Cystine SCHEMBL5018669 | 0.90 | PTGS1 (0.50) | NOS2NOS1NOS3ARG1ARG2 | |
| Cystine SCHEMBL8332360 | 0.90 | PTGS1 (0.50) | NOS2NOS1NOS3ARG1ARG2 | |
| SCHEMBL9200531 | 0.90 | NOS2 (0.35) | NOS2NOS1NOS3ARG1ARG2 | |
| Cystine SCHEMBL8332353 | 0.90 | PTGS1 (0.50) | NOS2NOS1NOS3ARG1ARG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026087109-A1 | PERSONAL CARE COMPOSITION BASED ON AN ACETYL AMINOACID COMPOUND AND A CYSTINE COMPOUND | UNILEVER IP HOLDINGS B.V. (NL) | 2026-04-30 | — | — | WO | claimed |
| CN-113527657-B | Polyethylene glycol modified cystine amide derivative, preparation and application thereof | 武汉纳乐吉生命科技有限公司 | 2023-05-30 | — | — | CN | claimed |
| CN-110386890-B | Drug-loaded nano hydrogel based on cysteamine derivatives and preparation method thereof | 沈阳药科大学 | 2021-06-18 | — | — | CN | claimed |
| WO-2026087109-A1 | PERSONAL CARE COMPOSITION BASED ON AN ACETYL AMINOACID COMPOUND AND A CYSTINE COMPOUND | UNILEVER IP HOLDINGS B.V. (NL) | 2026-04-30 | — | — | WO | disclosed |
| CN-121930144-A | Multifunctional hair cosmetic active raw material and preparation method and application thereof | 广州澳谷化妆品制造有限公司 | 2026-04-28 | — | — | CN | disclosed |
| US-12486241-B2 | Cystine diamide analogs for cystinuria | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2025-12-02 | — | — | US | disclosed |
| CN-113527657-B | Polyethylene glycol modified cystine amide derivative, preparation and application thereof | 武汉纳乐吉生命科技有限公司 | 2023-05-30 | — | — | CN | disclosed |
| CN-113527657-B | Polyethylene glycol modified cystine amide derivative, preparation and application thereof | 武汉纳乐吉生命科技有限公司 | 2023-05-30 | — | — | CN | disclosed |
| CN-113527657-B | Polyethylene glycol modified cystine amide derivative, preparation and application thereof | 武汉纳乐吉生命科技有限公司 | 2023-05-30 | — | — | CN | disclosed |
| US-20230043330-A1 | Cystine Diamide Analogs For Cystinuria | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2023-02-09 | — | — | US | disclosed |
| EP-4072537-A1 | CYSTINE DIAMIDE ANALOGS FOR CYSTINURIA | Rutgers, the State University of New Jersey (US) | 2022-10-19 | — | — | EP | disclosed |
| CN-115103669-A | Cystine diamide analogs for cystinuria | 新泽西鲁特格斯州立大学 | 2022-09-23 | — | — | CN | disclosed |
| CN-113527657-A | Polyethylene glycol modified cysteamine derivative, preparation and application thereof | 武汉纳乐吉生命科技有限公司 | 2021-10-22 | — | — | CN | disclosed |
| US-5175338-A | Anticoagulants, vasodilation, antilipemic agents | TEIJIN LIMITED (JP) | 1992-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12486241-B2 | Cystine diamide analogs for cystinuria | CTH, CBS, SLC7A11 | NOS2 1945/4885NOS1 1583/4885NOS3 1505/4885 |
| US-20230043330-A1 | Cystine Diamide Analogs For Cystinuria | CTH, CBS, SLC7A11 | NOS2 1945/4885NOS1 1583/4885NOS3 1505/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.